Historique
![EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene). In accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended)](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_82937.webp?v=1771250837)
Rapport
EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene). In accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended)
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année
2020
Page(s) :
22 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
;
Luxembourg : Publications Office of the European Union
Collection :
Initial reports
ISBN :
978-92-9497-491-4
Domaine :
Autres substances / Other substances
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Organismes
OEDT
Thésaurus géographique
EUROPE
;
UNION EUROPEENNE
Thésaurus mots-clés
OPIOIDES
;
DROGUES DE SYNTHESE
;
LEGISLATION
;
ANALGESIQUES
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
FACTEUR DE RISQUE
;
CHIMIE
;
PHARMACOLOGIE
;
SAISIE
;
TOXICOLOGIE
Résumé :
Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended). Its purpose is to provide scientific evidence to the Commission to allow it to make an informed decision regarding whether or not there is a need to request a risk assessment on a new psychoactive substance.